Fundz

Tasso and ARUP Laboratories form partnership for decentralized clinical research biomarker testing

Feb 03, 2025

Contract Type

partnership

SeattleOtherInformation TechnologyBiotechnologySoftwareMobileHealth CareEducation

Description

Tasso and ARUP Laboratories have announced a partnership to provide a combined offering for decentralized clinical research biomarker testing. This partnership aims to enhance the capabilities for biomarker testing in decentralized clinical research.

Company Information

Company

Tasso

Location

Seattle, Washington, United States

About

Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants from the Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, and the National Institutes of Health, by investments from RA Capital, the D.E. Shaw group, Senvest, InCube, SVB Innovation Fund, Hambrecht Ducera Growth Ventures, J2V, Merck Global Health Innovation Fund, Foresite Capital, Vertical Venture Partners, Techstars, and Cedars Sinai, and by co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.

Predictive Intelligence
Strategic

ML-powered predictions for Tasso's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Tasso signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.